LFST LifeStance Health Group, Inc.
Services-Health Services · Nasdaq · SEC CIK 1845257 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $455.86M | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | $332.97M | $325.48M |
| SG&A expense | $113.39M | $108.14M | $100.33M | $94.78M | $95.61M | $97.38M | $94.43M | $93.71M |
| Operating income | $33.08M | $30.65M | $22.28M | $18.08M | $7.41M | -$2.95M | $1.60M | $1.06M |
| Interest expense | $2.49M | $2.63M | $1.79M | $2.88M | $2.81M | $2.90M | $3.07M | $9.40M |
| Pretax income | $27.40M | $27.46M | $19.76M | $15.20M | $4.57M | -$5.94M | -$1.47M | -$8.88M |
| Income tax | $5.02M | $3.85M | $5.52M | $3.54M | $3.50M | -$2.15M | -$2.18M | -$1.76M |
| Net income | $22.39M | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | $709,000 | -$7.11M |
| EBITDA | $45.13M | $41.96M | $32.65M | $28.43M | $17.75M | $7.69M | $11.89M | $11.18M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Weighted avg. shares (diluted) | 391.22M | 387.30M | 395.08M | — | 388.89M | 386.73M | 390.67M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $218.82M | $225.94M | $194.80M | $248.64M | $203.90M | $188.93M | $134.34M | $154.57M |
| Receivables | $120.94M | $110.96M | $122.92M | $95.71M | $121.07M | $129.48M | $140.37M | $131.80M |
| Current assets | $376.78M | $377.97M | $355.91M | $416.20M | $360.38M | $358.85M | $304.63M | $312.51M |
| PP&E, net | $166.43M | $164.70M | $161.47M | $161.58M | $162.67M | $160.62M | $163.72M | $166.04M |
| Goodwill | $1.31B | $1.30B | $1.30B | $1.29B | $1.29B | $1.29B | $1.29B | $1.29B |
| Intangibles | $170.04M | $172.81M | $175.14M | $177.66M | $180.75M | $183.97M | $187.33M | $190.80M |
| Total assets | $2.19B | $2.18B | $2.15B | $2.20B | $2.15B | $2.15B | $2.10B | $2.12B |
| Current liabilities | $261.13M | $274.75M | $239.73M | $251.96M | $228.56M | $242.28M | $207.38M | $228.89M |
| Short-term debt | $14.50M | $14.50M | $18.12M | $14.50M | $12.69M | $10.88M | $9.06M | $7.25M |
| Long-term debt | $255.52M | $258.99M | $262.46M | $265.93M | $269.39M | $272.86M | $276.32M | $279.79M |
| Total debt | $270.02M | $273.49M | $280.58M | $280.43M | $282.08M | $283.73M | $285.38M | $287.04M |
| Total liabilities | $693.89M | $704.35M | $668.47M | $682.92M | $656.23M | $672.88M | $647.57M | $672.01M |
| Shareholders' equity | $1.49B | $1.48B | $1.48B | $1.52B | $1.49B | $1.47B | $1.46B | $1.45B |
| Net debt | $51.21M | $47.55M | $85.79M | $31.79M | $78.18M | $94.80M | $151.05M | $132.47M |
| Shares outstanding | 380.19M | 382.02M | 387.81M | 388.32M | 389.00M | 389.08M | 388.83M | 382.74M |
| Cash flow statement | ||||||||
| Operating cash flow | $37.02M | $99.91M | $33.11M | $57.56M | $27.29M | $64.40M | -$3.09M | $62.32M |
| Capital expenditure | $14.65M | $11.99M | $10.77M | $10.91M | $10.29M | $7.75M | $7.17M | $6.30M |
| Free cash flow | $22.36M | $87.92M | $22.34M | $46.65M | $17.00M | $56.64M | -$10.26M | $56.02M |
| Investing cash flow | -$15.21M | -$17.89M | -$13.91M | -$10.91M | -$10.29M | -$7.75M | -$7.17M | -$6.30M |
| Financing cash flow | -$28.93M | -$50.88M | -$73.04M | -$1.91M | -$2.02M | -$2.05M | -$9.97M | -$4.06M |
| Depreciation & amortization | $12.05M | $11.31M | $10.37M | $10.35M | $10.34M | $10.64M | $10.29M | $10.12M |
| Stock-based compensation | $18.17M | $19.75M | $15.20M | $16.70M | $18.30M | $21.12M | $18.58M | $16.15M |
| Share buybacks | $24.80M | $48.52M | $49.11M | — | $0 | $0 | $0 | — |
Free plan shows the latest 8 periods; Pro shows all 26 🔒
· This company does not report gross profit in XBRL.
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.